MyAverix Finance
HK · Healthcare
China NT Pharma Group Co Ltd (1011)
Drug Manufacturers - Specialty & Generic
China NT Pharma Group Co Ltd (1011) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $569.40M, P/E ratio is 18.00, net margin is -107.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1011
China NT Pharma Group Co Ltd (1011) — FAQ
What is China NT Pharma Group Co Ltd's market cap?
China NT Pharma Group Co Ltd (1011) has a reported market cap of $569.40M (data as of 2026-05-21).
What is 1011's P/E ratio?
The price-to-earnings (P/E) ratio for China NT Pharma Group Co Ltd (1011) is 18.00 (data as of 2026-05-21).
Does China NT Pharma Group Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for China NT Pharma Group Co Ltd (1011). Check the MyAverix Finance app for the latest dividend data.
What sector is China NT Pharma Group Co Ltd in?
China NT Pharma Group Co Ltd (1011) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 1011 listed on?
1011 is listed on HK.
What is China NT Pharma Group Co Ltd's net margin?
China NT Pharma Group Co Ltd (1011) reports a net margin of -107.8% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.